Allergic rhinitis (AR) is a global health problem that causes major illnesses and disabilities
worldwide. Epidemiologic studies have demonstrated that the prevalence of AR has …

Comorbid conditions (comorbidities) can complicate the diagnosis and management of
asthma. In different age groups, comorbid conditions can present varying challenges …

Compared to intramuscular vaccines, nasally administered vaccines have the advantage of
inducing local mucosal immune responses that may block infection and interrupt …

Background: Probiotics may prevent the allergic response development due to their anti-
inflammatory and immunomodulatory effects. The aim of this study is to determine if the …

Nasal obstruction (NO) is defined as the subjective perception of discomfort or difficulty in
the passage of air through the nostrils. It is a common reason for consultation in primary and …

Introduction Obesity can complicate IgE-mediated allergic diseases. In the present study, we
aimed to investigate the ability of obesity-related concentrations of leptin to modulate the in …

Background Obesity has often been associated with severe allergic asthma (AA). Here, we
analyzed the frequency of different circulating CD4+ T‐cell subsets from lean, overweight …

An HPMC-based nasal spray solution containing human IgG1 antibodies against SARS-
CoV-2 (nasal antibody spray or NAS) was developed to strengthen COVID-19 management …

Background Allergic rhinitis (AR) is characterized by the occurrence of at least 2 symptoms
of nasal itching, nasal blockage, rhinorrhea, and sneezing, when not afflicted with a cold or …

Montelukast is a leukotriene receptor antagonist (LTRA) commonly prescribed for asthma,
allergic rhinitis and sleep-related breathing disorders. Recently, some studies have reported …